Infectious Diseases Search
Infectious Diseases Infectious Diseases
varicella-zoster%20virus%20infection
VARICELLA-ZOSTER VIRUS INFECTION
Varicella, also known as chickenpox, is a self-limited benign disease caused by primary varicella-zoster virus (VZV) infection characterized by fever, malaise, and generalized pruritic vesicular rash.
The average incubation period is 14-16 days. It is transmitted via direct contact with vesicular fluid or inhalation of aerosolized respiratory secretions or via droplet route during face-to-face contact.
Hallmark sign is pruritic rash that begins in the scalp and face which eventually spreads to the trunks and extremities.
Drug Information

Indication: Vaccination against varicella in individuals ≥12 mth.

Indication: Prevention of herpes zoster (shingles) & postherpetic neuralgia; reduction of acute & chronic zoster-a...

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: HSV skin infections including initial & recurrent genital herpes labialis.

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Indication: HSV skin infection including genital herpes & herpes labialis.

Indication: Herpes zoster. Accelerates the resolution of pain by reducing the duration & proportion of patients w/ zos...

Indication: Promoting resolution of acute clinical manifestations of mucocutaneous HSV infections in immunocompromised pat...

Indication: Herpes simplex skin infections including initial & recurrent labial & genital herpes simplex infection...

Dosage: Adult Herpes simplex infections 200 mg 5 times daily at 4-hrly intervals for 5 days. Severely immunocompromise

1  /  4
1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Losartan does not reduce inflammation, fibrosis in HIV patients
Audrey Abella, 27 Mar 2020
The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.